You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Harvard Business School
McKesson
AstraZeneca
Express Scripts

Last Updated: January 21, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VUSION

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for VUSION

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00702507 Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants Completed GlaxoSmithKline Phase 4 2007-05-01 The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug.
NCT00702507 Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants Completed Stiefel, a GSK Company Phase 4 2007-05-01 The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug.
NCT01118910 Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo Completed Image Dermatology P.C. Phase 0 2010-04-01 The purpose of this study is to determine if people with moist, red, patches on their skin in body folds would benefit treatment of those areas with an FDA-approved drug called Vusion.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for VUSION

Condition Name

Condition Name for VUSION
Intervention Trials
Intertrigo 1
Diaper Rash 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for VUSION
Intervention Trials
Intertrigo 1
Diaper Rash 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for VUSION

Trials by Country

Trials by Country for VUSION
Location Trials
United States 5
Ecuador 1
Dominican Republic 1
Panama 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for VUSION
Location Trials
New Jersey 1
Texas 1
Georgia 1
Florida 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for VUSION

Clinical Trial Phase

Clinical Trial Phase for VUSION
Clinical Trial Phase Trials
Phase 4 1
Phase 0 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for VUSION
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for VUSION

Sponsor Name

Sponsor Name for VUSION
Sponsor Trials
Image Dermatology P.C. 1
Stiefel, a GSK Company 1
GlaxoSmithKline 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for VUSION
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Medtronic
Dow
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.